Excellence in Product Innovation Award
Dallas, October 21, 2021 -- Based on recent research on the gene therapy market, Lucintel is pleased to announce Biogen’s SPINRAZA® as the recipient of the “2021 Product Innovation Award in the Gene Therapy Market”. Lucintel chose Biogen for this award because of its novel Ionis’ proprietary antisense technology, which provides an antisense oligonucleotide (ASO) medicine to treat infants, children, and adults with 5q spinal muscular atrophy (SMA), including pre-symptomatic and symptomatic SMA Types 1, 2 and 3. Thus, plays a vital role in the treatment landscape for SMA with greater efficiency and safety.
Biogen’s SPINRAZA® is designed to treat the root cause of SMA. It helps in altering the splicing of SMN2 pre-mRNA, which results in increase production of full-length survival motor neuron (SMN) protein that is critical to maintaining motor neurons. It is administered by intrathecal injection into the fluid surrounding the spinal cord where motor neurons reside to deliver the treatment where the disease starts.
Biogen’s SPINRAZA® is the first FDA-approved medicine for the treatment of spinal muscular atrophy (SMA). It is a SMN-enhancing therapy, which works by targeting the SMN2 gene resulting in making it more complete protein. SMA is a neuromuscular disease as it originates in the central nervous system (CNS) and affects the motor neurons that power the muscles in the body.
Lucintel’s awards in innovation and industry excellence recognize outstanding achievements and latest endeavors by companies in various industries, identifying the most successful, innovative, and forward-thinking companies and products in business today. Lucintel awards are based on systematic and detailed research on the relevant markets to identify and recognize the most successful recent innovations. These initiatives enable companies to demonstrate high levels of industry impact and benefits to end users. To know more contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com
About Lucintel
Lucintel, a premier market research and Management Consulting firm based in Dallas, Texas, has served over 1,000 clients for over 20 years. With our in-depth analysis and sage advice, Lucintel offers solutions for your growth through game changing ideas and analysis of robust markets and unmet needs. Lucintel has been quoted in esteemed publications, including The Wall Street Journal, ZACKS, and The Financial Times. For further information, visit www.lucintel.com.
About Biogen
Biogen is based in United States and is pioneers in neuroscience. It develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen’s SPINRAZA® is the first approved treatment for spinal muscular atrophy commercializes biosimilar of advanced biologics as shown in www.spinraza.com/. Company focuses on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain. For further information, www.biogen.com
Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Enable GingerCannot connect to Ginger Check your internet connection
or reload the browserDisable in this text fieldRephraseRephrase current sentenceEdit in Ginger
The price and demand analysis on above is published monthly for various regions. Lucintel analysts collect supply, demand and price data from various suppliers and consumers on a monthly basis and also analyzes news on supply and demand issues, production, and price trends. This allows Lucintel to publish unbiased assessments on price and demand movements to help you make confident business decisions on your negotiation or business issues.
Become a valued Lucintel member to gain access to thousands of market data, price and demand trends, and more for one low rate ($89 / month to $1,850 / month). Analyst and sales support included.
Try Demo
Buy Now